Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Study of GSK1120212 in Solid Tumors or Leukemia
NCT01376310Phase 2Terminated
- Sponsor
- Novartis
- Start
- Nov 2010
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of trametinib in solid tumor, leukemia, sponsored by Novartis. Started Nov 2010; status: terminated.
02
Drugs
trametinib
03
Conditions
solid tumorleukemia
Beyond the preview
Go deeper on NCT01376310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376310.